Esophageal cancer epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(24 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Esophageal cancer}}
{{Esophageal cancer}}
{{CMG}}; {{AE}} {{Rim}}{{PSD}} {{HM}}
{{CMG}};{{AE}}{{HM}}


==Overview==
==Overview==
The majority of esophageal cancer cases are reported in the “Asian belt” area which includes China, Japan, India, Iran, Turkey, among other Middle Eastern countries.
 
Esophageal cancer is the 6th leading cause of death from cancer and the 8th most common cancer in the world. The [[prevalence]] of esophageal cancer worldwide is about 3.5 per 100,000. In the United States, about 17000 new cases are diagnosed every year and 4.2 per 100,000 Americans has esophageal cancer. Esophageal cancer is mostly present in the "Asian belt" region which includes, China, Japan, India and Iran.
 
==Epidemiology and Demographics==
==Epidemiology and Demographics==
Estimated new cases and deaths from esophageal cancer in the United States in 2016:
*New cases: 16,940
===Incidence===
*Deaths: 15,690
*The [[incidence]] of esophageal cancer is approximately 3.5 per 100,000 individuals worldwide.<ref name="pmid24039351">{{cite journal |vauthors=Zhang Y |title=Epidemiology of esophageal cancer |journal=World J. Gastroenterol. |volume=19 |issue=34 |pages=5598–606 |year=2013 |pmid=24039351 |pmc=3769895 |doi=10.3748/wjg.v19.i34.5598 |url=}}</ref>
*The [[incidence]] of invasive esophageal cancer was 4.2 per 100,000 individuals in the United States.
*The [[American Cancer Society]] estimates that by the end of 2017, there will be 16,960 new cases of esophageal cancer in the United States .


Worldwide, the predominant type of esophageal cancer is [[squamous cell carcinoma]].  However, the rate of [[adenocarcinoma]] outnumbers [[squamous cell carcinoma]] in the Unites States and some European countries.<ref name="pmid24039351">{{cite journal| author=Zhang Y| title=Epidemiology of esophageal cancer. | journal=World J Gastroenterol | year= 2013 | volume= 19 | issue= 34 | pages= 5598-606 | pmid=24039351 | doi=10.3748/wjg.v19.i34.5598 | pmc=PMC3769895 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24039351  }} </ref> 
===Prevalence===
===Prevalence===
* The prevalence of esophageal cancer differs among countries. In fact, esophageal cancer is most common in the area of the “Asian belt” which includes China, Japan, India, Iran, Turkey, among other Middle Eastern countries.<ref name="pmid23374478">{{cite journal| author=Pennathur A, Gibson MK, Jobe BA, Luketich JD| title=Oesophageal carcinoma. | journal=Lancet | year= 2013 | volume= 381 | issue= 9864 | pages= 400-12 | pmid=23374478 | doi=10.1016/S0140-6736(12)60643-6 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23374478  }} </ref>
*In 2014, the [[prevalence]] of esophageal cancer was estimated to be 7.25 cases per 100,000 individuals in the United States.<ref name="pmid24039351">{{cite journal |vauthors=Zhang Y |title=Epidemiology of esophageal cancer |journal=World J. Gastroenterol. |volume=19 |issue=34 |pages=5598–606 |year=2013 |pmid=24039351 |pmc=3769895 |doi=10.3748/wjg.v19.i34.5598 |url=}}</ref>
* In the United States, the age-adjusted [[prevalence]] of invasive esophageal cancer is 8.6 per 100,000 in 2011.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
 
===Incidence===


In 2011, the age-adjusted incidence of invasive esophageal cancer was 4.45 per 100,000 persons in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
===Case-fatality rate/Mortality rate===
*Between 2010 - 2014, the [[incidence]] of esophageal cancer in the United States was approximately 4.2 per 100,000 individuals with a case-fatality rate/mortality rate of 4.1 per 100,000 individuals.<ref name="pmid24039351">{{cite journal |vauthors=Zhang Y |title=Epidemiology of esophageal cancer |journal=World J. Gastroenterol. |volume=19 |issue=34 |pages=5598–606 |year=2013 |pmid=24039351 |pmc=3769895 |doi=10.3748/wjg.v19.i34.5598 |url=}}</ref>
*Mortality rates from esophageal cancer are higher in blacks and white females than white males.<ref name="pmid240393514">{{cite journal |vauthors=Zhang Y |title=Epidemiology of esophageal cancer |journal=World J. Gastroenterol. |volume=19 |issue=34 |pages=5598–606 |year=2013 |pmid=24039351 |pmc=3769895 |doi=10.3748/wjg.v19.i34.5598 |url=}}</ref>


===Age===
===Age===
*The [[incidence]] of esophageal cancer increases with age; the median age at diagnosis is 67 years.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref><ref name="pmid240393513">{{cite journal |vauthors=Zhang Y |title=Epidemiology of esophageal cancer |journal=World J. Gastroenterol. |volume=19 |issue=34 |pages=5598–606 |year=2013 |pmid=24039351 |pmc=3769895 |doi=10.3748/wjg.v19.i34.5598 |url=}}</ref> 
*The age-adjusted [[incidence]] of invasive esophageal cancer worldwide by age category is:
**Under 65 years: 1.8 per 100,000
**65 and over: 22.5 per 100,000


* The risk of esophageal cancer increases with age. While the overall age-adjusted incidence of invasive esophageal cancer in the United States between 2007 and 2011 is 4.4 per 100,000, the age-adjusted incidence of invasive esophageal cancer by age category is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
===Race===
** Under 65 years: 1.8 per 100,000
*Esophageal [[adenocarcinoma]] usually affects individuals of the Caucasian race, whilst Black individuals are more likely to develop esophagus [[squamous cell carcinoma]]. <ref name="pmid16334494">{{cite journal |vauthors=Baquet CR, Commiskey P, Mack K, Meltzer S, Mishra SI |title=Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology |journal=J Natl Med Assoc |volume=97 |issue=11 |pages=1471–8 |year=2005 |pmid=16334494 |pmc=2594901 |doi= |url=}}</ref>
** 65 and over: 22.5 per 100,000
*More Black individuals are diagnosed with esophageal cancer then Caucasian individuals overall.<ref name="pmid240393512">{{cite journal |vauthors=Zhang Y |title=Epidemiology of esophageal cancer |journal=World J. Gastroenterol. |volume=19 |issue=34 |pages=5598–606 |year=2013 |pmid=24039351 |pmc=3769895 |doi=10.3748/wjg.v19.i34.5598 |url=}}</ref>
* In the United States, 68.5% of Caucasian subjects with esophageal cancer had [[adenocarcinoma]], whereas 80% of black individuals affected with esophageal cancer had [[squamous cell carcinoma]].


===Gender===
===Gender===
* In the United States, the age-adjusted [[prevalence]] of invasive esophageal cancer by gender in 2011 is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
*Men are more commonly affected by esophageal cancer than women. The male to female ratio is approximately 4 to 1.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
** In males: 0.0147%
** In females: 0.0036%
 
* In the United States, the delay-adjusted [[incidence]] of invasive esophageal cancer by gender in 2011 is:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
** In males: 7.83 per 100,000 persons
** In females: 1.83 per 100,000 persons
 
Shown below is an image depicting the delay-adjusted [[incidence]] and observed incidence of invasive esophageal cancer by gender and race in the United States between 1975 and 2011.  These graphs are adapted from [[SEER]]: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
 
[[Image:delay adjusted incidence of invasive esophageal cancer by gender and race in the United States.PNG|824x824px]]
 
===Race===
* While squamous cell carcinoma is more common among black individuals, adenocarcinoma is more common among white people.<ref name="pmid24039351">{{cite journal| author=Zhang Y| title=Epidemiology of esophageal cancer. | journal=World J Gastroenterol | year= 2013 | volume= 19 | issue= 34 | pages= 5598-606 | pmid=24039351 | doi=10.3748/wjg.v19.i34.5598 | pmc=PMC3769895 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24039351  }} </ref>  In the United States, 68.5% of white subjects with esophageal cancer had [[adenocarcinoma]], whereas 80% of black individuals affected with esophageal cancer had [[squamous cell carcinoma]] between 2007 and 2011.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
 
* Shown below is a table depicting the age-adjusted [[prevalence]] of invasive esophageal cancer by race in 2011 in the United States.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
 
{| style="cellpadding=0; cellspacing= 0; width: 600px;"
|-
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align="center" | || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align="center" |'''All Races''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align="center" |'''White''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align="center" |'''Black''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align="center" |'''Asian/Pacific Islander'''  || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align="center" |'''Hispanic'''
|-
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align="center" |'''Age-adjusted prevalence'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" |8.6 per 100,000 || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" |9.4 per 100,000|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" |7 per 100,000 || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" | 4.7 per 100,000 || style="font-size: 100; padding: 0 5px; background: #B8B8B8" align="left" |4.8 per 100,000
|}
 
Shown below is an image depicting the incidence of invasive esophageal cancer by race in the United States between 1975 and 2011.<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
 
<figure-inline class="mw-default-size">[[Image:Incidence of invasive esophageal cancer by race in the United States.PNG|469x469px]]</figure-inline>


<small> API: Asian/Pacific Islander; AI/AN: American Indian/ Alaska Native</small>
===Region===
*The majority of esophageal cancer cases are reported in in the area of the “Asian belt” which includes China, Japan, India, Iran, Turkey, among other Middle Eastern countries.<ref name="pmid23374478">{{cite journal| author=Pennathur A, Gibson MK, Jobe BA, Luketich JD| title=Oesophageal carcinoma. | journal=Lancet | year= 2013 | volume= 381 | issue= 9864 | pages= 400-12 | pmid=23374478 | doi=10.1016/S0140-6736(12)60643-6 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23374478}}</ref>
*In China, the incidence rate of esophageal cancer is 16.7 per 100 000 population.<ref name="pmid23629646">{{cite journal |vauthors=Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y, Ueda J, Wei W, Inoue M, Tanaka H |title=Epidemiology of esophageal cancer in Japan and China |journal=J Epidemiol |volume=23 |issue=4 |pages=233–42 |year=2013 |pmid=23629646 |pmc=3709543 |doi= |url=}}</ref>


===Percent Distribution of Invasive Esophageal Cancer by Histology===
===Developing Countries vs. Developed Countries===
Among patients with histologically confirmed cases of invasive esophageal cancer, the percent distribution of the types of the disease between 2007 and 2011 in the United States are:<ref name="SEER">Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.</ref>
*Worldwide, the predominant type of esophageal cancer is [[squamous cell carcinoma]].<ref name="pmid24039351">{{cite journal| author=Zhang Y| title=Epidemiology of esophageal cancer. | journal=World J Gastroenterol | year= 2013 | volume= 19 | issue= 34 | pages= 5598-606 | pmid=24039351 | doi=10.3748/wjg.v19.i34.5598 | pmc=PMC3769895 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24039351}} </ref>  
* [[Carcinoma]]: 99.1%
*However, the rate of [[adenocarcinoma]] outnumbers [[squamous cell carcinoma]] in developed countries like the United States and some European countries.
:* [[Epidermoid carcinoma]]: 33.7%
*[[Squamous cell carcinoma]] is predominant in developing countries.
::: 1. [[Squamous cell carcinoma]]: 33.6%
::: 2. [[Transitional cell carcinoma]]
::: 3. [[Basal cell carcinoma]]
:* [[Adenocarcinoma]]: 60.7%
:* Other specific carcinoma: 1.5%
:* Carcinoma not otherwise specified: 3.2%
* Other specific types: 0.3%
* Unspecified: 0.6%


==References==
==References==
Line 78: Line 53:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Medicine]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Surgery]]
[[Category:Surgery]]

Latest revision as of 15:47, 5 January 2018

Esophageal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Esophageal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esophageal cancer epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esophageal cancer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esophageal cancer epidemiology and demographics

CDC on Esophageal cancer epidemiology and demographics

Esophageal cancer epidemiology and demographics in the news

Blogs on Esophageal cancer epidemiology and demographics

Directions to Hospitals Treating Esophageal cancer

Risk calculators and risk factors for Esophageal cancer epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Hadeel Maksoud M.D.[2]

Overview

Esophageal cancer is the 6th leading cause of death from cancer and the 8th most common cancer in the world. The prevalence of esophageal cancer worldwide is about 3.5 per 100,000. In the United States, about 17000 new cases are diagnosed every year and 4.2 per 100,000 Americans has esophageal cancer. Esophageal cancer is mostly present in the "Asian belt" region which includes, China, Japan, India and Iran.

Epidemiology and Demographics

Incidence

  • The incidence of esophageal cancer is approximately 3.5 per 100,000 individuals worldwide.[1]
  • The incidence of invasive esophageal cancer was 4.2 per 100,000 individuals in the United States.
  • The American Cancer Society estimates that by the end of 2017, there will be 16,960 new cases of esophageal cancer in the United States .

Prevalence

  • In 2014, the prevalence of esophageal cancer was estimated to be 7.25 cases per 100,000 individuals in the United States.[1]

Case-fatality rate/Mortality rate

  • Between 2010 - 2014, the incidence of esophageal cancer in the United States was approximately 4.2 per 100,000 individuals with a case-fatality rate/mortality rate of 4.1 per 100,000 individuals.[1]
  • Mortality rates from esophageal cancer are higher in blacks and white females than white males.[2]

Age

  • The incidence of esophageal cancer increases with age; the median age at diagnosis is 67 years.[3][4]
  • The age-adjusted incidence of invasive esophageal cancer worldwide by age category is:
    • Under 65 years: 1.8 per 100,000
    • 65 and over: 22.5 per 100,000

Race

  • Esophageal adenocarcinoma usually affects individuals of the Caucasian race, whilst Black individuals are more likely to develop esophagus squamous cell carcinoma. [5]
  • More Black individuals are diagnosed with esophageal cancer then Caucasian individuals overall.[6]
  • In the United States, 68.5% of Caucasian subjects with esophageal cancer had adenocarcinoma, whereas 80% of black individuals affected with esophageal cancer had squamous cell carcinoma.

Gender

  • Men are more commonly affected by esophageal cancer than women. The male to female ratio is approximately 4 to 1.[3]

Region

  • The majority of esophageal cancer cases are reported in in the area of the “Asian belt” which includes China, Japan, India, Iran, Turkey, among other Middle Eastern countries.[7]
  • In China, the incidence rate of esophageal cancer is 16.7 per 100 000 population.[8]

Developing Countries vs. Developed Countries

References

  1. 1.0 1.1 1.2 1.3 Zhang Y (2013). "Epidemiology of esophageal cancer". World J. Gastroenterol. 19 (34): 5598–606. doi:10.3748/wjg.v19.i34.5598. PMC 3769895. PMID 24039351.
  2. Zhang Y (2013). "Epidemiology of esophageal cancer". World J. Gastroenterol. 19 (34): 5598–606. doi:10.3748/wjg.v19.i34.5598. PMC 3769895. PMID 24039351.
  3. 3.0 3.1 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
  4. Zhang Y (2013). "Epidemiology of esophageal cancer". World J. Gastroenterol. 19 (34): 5598–606. doi:10.3748/wjg.v19.i34.5598. PMC 3769895. PMID 24039351.
  5. Baquet CR, Commiskey P, Mack K, Meltzer S, Mishra SI (2005). "Esophageal cancer epidemiology in blacks and whites: racial and gender disparities in incidence, mortality, survival rates and histology". J Natl Med Assoc. 97 (11): 1471–8. PMC 2594901. PMID 16334494.
  6. Zhang Y (2013). "Epidemiology of esophageal cancer". World J. Gastroenterol. 19 (34): 5598–606. doi:10.3748/wjg.v19.i34.5598. PMC 3769895. PMID 24039351.
  7. Pennathur A, Gibson MK, Jobe BA, Luketich JD (2013). "Oesophageal carcinoma". Lancet. 381 (9864): 400–12. doi:10.1016/S0140-6736(12)60643-6. PMID 23374478.
  8. Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y, Ueda J, Wei W, Inoue M, Tanaka H (2013). "Epidemiology of esophageal cancer in Japan and China". J Epidemiol. 23 (4): 233–42. PMC 3709543. PMID 23629646.


Template:WikiDoc Sources